Metastasis is the process by which cancer cells spread from a primary tumor to distant organs, and it is responsible for most cancer deaths. It is not a random event but a multistep cascade that only a tiny fraction of tumor cells successfully complete.

Cancer cells first acquire invasive traits within the primary tumor, often driven by genetic instability and signals from surrounding stromal cells and the immune system. They undergo changes resembling epithelial to mesenchymal transition, loosen cell–cell junctions, degrade extracellular matrix and enter nearby blood or lymphatic vessels.

In the circulation, tumor cells face shear stress and immune attack. Many travel as clusters or associate with platelets, which shield them and promote survival. A small subset becomes circulating tumor cells with stem like properties that can initiate new tumors.

Colonization of distant organs is the most selective and least understood step. Successful cells must exit vessels, adapt to the local microenvironment and re establish growth. Organ specific patterns of spread reflect both blood flow routes and “seed and soil” compatibility between cancer cells and target tissues.

The metastatic microenvironment includes fibroblasts, immune cells, endothelial cells and extracellular matrix, all reshaped by cancer secreted factors and extracellular vesicles. These signals can even precondition distant sites, creating pre metastatic niches.

Clinically, metastasis research informs early detection via circulating tumor cells and DNA, risk prediction, and targeted therapies that interfere with invasion, intravasation, immune evasion and niche formation. Despite its inefficiency, metastasis drives relapse and remains a central challenge in oncology.